I know the news about Moderna is hype right now but technicals are showing a bearish divergence from the RSI.
Based on the "Lazy Elliott" Forecast, if you're going to assume this plot to be an impulse wave, wave 3 from this perspective might be complete already.
One way to verify is if the price closes below the 161.8% level, it might signal the start of wave...
The uptrend is mainly based on the good news (Fundamental Analysis) and the technical Analysis respects the good news of this stock.
Hold before going long - wait the right time to buy, even if we are late on this stock - Target Price of $105 based on Fundamental Analysis:
Shares jumped 20% on Monday after the company revealed positive early results from its...
www.zerohedge.com
As I said in the last update of this stock, I do not doubt its bullishness , however, in the short term, under my own experience (as I commented to another TradinView user) when a large unexpected movement occurs, this movement tends to correct itself slightly .
Remember the title of this publication. STRADDLE RATIO.
In the long term it is...
www.thedailybeast.com
Although the left-wing US media uses inconclusive data to make anti-trump electoral propaganda, it is interesting to operate a straddle ratio in this situation.
Personally I think a fall is more likely; When sensational news appears pointing in one direction, it makes everyone go after like mosquitoes to the light, and buy. It is somewhat...
First off, please don't take anything I say seriously or as financial advice. As always, this is on opinion based basis. Moderna's Covid19 vaccine for mRNA-1273 is reaching Phase 2 clinical trails by the FDA which is further ahead than most of its small competitors and bio-pharmaceutical corporations. As always, you see the big giant crushing the small one. This...
SO Moderna spiked from roughly $19.07 to $28 est. in less than 45 minutes after rumors broke into confirmations ending with headlines as Mordova has officially announced a vaccination for COVID-19 has been developed yet with months of red tape ahead of us (still have yet to undergo animal testing, clinical trials, human testing, then once the vaccination has been...
Moderna is one of the best pick for COVID-19 vaccine. They have already started dosing patients and expect the vaccine to be available for high-risk people like healthcare workers in the Fall this year.
The strength is rising and needs to close above $36 by the end of next week.
This is a great example how forward looking indicators, when used in conjunction, can provide the most accurate support and resistance levels. While most indicators are lagging, projection indicators that help define major price pivots are predictive. MRNA ran into the upper MSP boundaries and has been trading between the bands with TDS lines from prior signals...
